Carillion plc’s Buy Rating Reaffirmed at Liberum Capital (CLLN)
Carillion plc (LON:CLLN)‘s stock had its “buy” rating reaffirmed by equities research analysts at Liberum Capital in a research note issued to investors on Wednesday. They currently have a GBX 300 ($5.02) target price on the stock. Liberum Capital’s price target indicates a potential downside of 10.90% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Carillion plc in a research note on Monday. They now have a GBX 315 ($5.27) price target on the stock. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Carillion plc in a research note on Friday, August 15th. They now have a GBX 385 ($6.44) price target on the stock. Finally, analysts at Investec reiterated a “buy” rating on shares of Carillion plc in a research note on Thursday, August 14th. They now have a GBX 380 ($6.35) price target on the stock. One investment analyst has rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the stock. Carillion plc currently has a consensus rating of “Buy” and a consensus price target of GBX 371.82 ($6.22).
Shares of Carillion plc (LON:CLLN) opened at 327.20 on Wednesday. Carillion plc has a 52 week low of GBX 283.00 and a 52 week high of GBX 395.00. The stock’s 50-day moving average is GBX 334.7 and its 200-day moving average is GBX 351.2. The company’s market cap is £1.407 billion.
The company also recently announced a dividend, which is scheduled for Wednesday, November 5th. Stockholders of record on Wednesday, September 3rd will be paid a dividend of GBX 5.60 ($0.09) per share. This represents a dividend yield of 1.62%. The ex-dividend date is Wednesday, September 3rd.
Carillion plc is an integrated support services company, with a portfolio of public private partnership projects and construction capabilities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.